Literature DB >> 34526675

Characterization of TGFβ-specific CD4+T cells through the modulation of TGFβ expression in malignant myeloid cells.

Rasmus Erik Johansson Mortensen1, Morten Orebo Holmström1,2, Mads Hald Andersen3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34526675      PMCID： PMC8545951          DOI： 10.1038/s41423-021-00770-0

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  8 in total

1.  Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators.

Authors:  Rikke Baek Sørensen; Sine Reker Hadrup; Inge Marie Svane; Mads Christian Hjortsø; Per Thor Straten; Mads Hald Andersen
Journal:  Blood       Date:  2010-11-15       Impact factor: 22.113

Review 2.  Emerging Roles of Th9 Cells as an Anti-tumor Helper T Cells.

Authors:  Rucha Chandwaskar; Amit Awasthi
Journal:  Int Rev Immunol       Date:  2019-08-12       Impact factor: 5.311

Review 3.  Transforming Growth Factor-β Signaling in Immunity and Cancer.

Authors:  Eduard Batlle; Joan Massagué
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

4.  HLA-restricted CTL that are specific for the immune checkpoint ligand PD-L1 occur with high frequency in cancer patients.

Authors:  Shamaila Munir; Gitte Holmen Andersen; Özcan Met; Marco Donia; Thomas Mørch Frøsig; Stine Kiaer Larsen; Tobias Wirenfeldt Klausen; Inge Marie Svane; Mads Hald Andersen
Journal:  Cancer Res       Date:  2013-01-17       Impact factor: 12.701

5.  Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an epitope derived from indoleamine 2,3 dioxygenase.

Authors:  Trine Zeeberg Iversen; Lotte Engell-Noerregaard; Eva Ellebaek; Rikke Andersen; Stine Kiaer Larsen; Jon Bjoern; Claus Zeyher; Cécile Gouttefangeas; Birthe Moerk Thomsen; Bente Holm; Per Thor Straten; Anders Mellemgaard; Mads Hald Andersen; Inge Marie Svane
Journal:  Clin Cancer Res       Date:  2013-11-11       Impact factor: 12.531

Review 6.  Anti-regulatory T cells.

Authors:  Mads Hald Andersen
Journal:  Semin Immunopathol       Date:  2016-09-27       Impact factor: 9.623

7.  Cytotoxic T cells isolated from healthy donors and cancer patients kill TGFβ-expressing cancer cells in a TGFβ-dependent manner.

Authors:  Morten Orebo Holmström; Rasmus Erik Johansson Mortensen; Angelos Michail Pavlidis; Evelina Martinenaite; Stine Emilie Weis-Banke; Mia Aaboe-Jørgensen; Simone Kloch Bendtsen; Özcan Met; Ayako Wakatsuki Pedersen; Marco Donia; Inge Marie Svane; Mads Hald Andersen
Journal:  Cell Mol Immunol       Date:  2021-01-06       Impact factor: 22.096

Review 8.  Systemic CD4 Immunity as a Key Contributor to PD-L1/PD-1 Blockade Immunotherapy Efficacy.

Authors:  Miren Zuazo; Hugo Arasanz; Ana Bocanegra; Gonzalo Fernandez; Luisa Chocarro; Ruth Vera; Grazyna Kochan; David Escors
Journal:  Front Immunol       Date:  2020-11-30       Impact factor: 7.561
  8 in total
  1 in total

Review 1.  Tumor microenvironment antigens.

Authors:  Mads Hald Andersen
Journal:  Semin Immunopathol       Date:  2022-09-29       Impact factor: 11.759
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.